Rhythm Pharmaceuticals, Inc. Common Stock RYTM
$85.92
-0.55%
at last close
Financials (TTM)
- Revenue
- $217.16 million
- Net Income
- $-202,680,000
- Net Margin
- -93.33%
- Return on Equity
- -164.91%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 47.95
- Price / Sales
- 27.14
Over the trailing twelve months, Rhythm Pharmaceuticals, Inc. Common Stock generated revenue of $217.16 million and net income of $-202,680,000, a net margin of -93.33%.
At the last closing price of $85.92, RYTM trades at 27.14 times sales, with a market capitalization of $5.89 billion.
Key Stats
- Last Close
- $85.92
- Market Cap
- $5.89 billion
- 52-Week Range
- $55.31 – $122.20
- Average Volume
- 687K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.